Hyperfine, Inc.

NasdaqGM:HYPR 주식 보고서

시가총액: US$71.2m

Hyperfine 미래 성장

Future 기준 확인 2/6

Hyperfine is forecast to grow earnings and revenue by 7.2% and 20.8% per annum respectively while EPS is expected to grow by 7.4% per annum.

주요 정보

7.2%

수익 성장률

7.4%

EPS 성장률

Medical Equipment 수익 성장17.4%
매출 성장률20.8%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트09 Aug 2024

최근 미래 성장 업데이트

Recent updates

Hyperfine appoints Maria Sainz as President, CEO

Oct 06

Hyperfine GAAP EPS of -$0.33 misses by $0.06, revenue of $1.53M misses by $0.47M

Aug 10

Hyperfine stock plunges 14% as CEO Dave Scott steps down

Jun 29

Hyperfine (NASDAQ:HYPR) Is In A Good Position To Deliver On Growth Plans

Apr 04
Hyperfine (NASDAQ:HYPR) Is In A Good Position To Deliver On Growth Plans

Hyperfine: MR Imaging In A Swoop

Mar 09

수익 및 매출 성장 예측

NasdaqGM:HYPR - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/202624-38N/AN/A2
12/31/202519-40-45N/A2
12/31/202414-41-43N/A3
6/30/202412-41-41-41N/A
3/31/202412-42-42-41N/A
12/31/202311-44-43-42N/A
9/30/202310-47-48-47N/A
6/30/202310-49-52-51N/A
3/31/20238-62-59-59N/A
12/31/20227-73-73-72N/A
9/30/20226-86-77-75N/A
6/30/20224-89-75-72N/A
3/31/20223-81-70-67N/A
12/31/20211-65-50-47N/A
9/30/20211-46-39-37N/A
6/30/20211-35-34-32N/A
3/31/20211-26-26-25N/A
12/31/20200-23-23-22N/A

애널리스트 미래 성장 예측

수입 대 저축률: HYPR is forecast to remain unprofitable over the next 3 years.

수익 vs 시장: HYPR is forecast to remain unprofitable over the next 3 years.

고성장 수익: HYPR is forecast to remain unprofitable over the next 3 years.

수익 대 시장: HYPR's revenue (20.8% per year) is forecast to grow faster than the US market (8.9% per year).

고성장 수익: HYPR's revenue (20.8% per year) is forecast to grow faster than 20% per year.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: Insufficient data to determine if HYPR's Return on Equity is forecast to be high in 3 years time


성장 기업 발견